Dr Kurdi earned her PhD Degree in Biopharmaceutical Science in 2015 from University of Greenwich in UK.

Dr Kurdi is currently working as Regulatory Affairs & Public Policy Senior Manager for EMEA Region at USP. USP is a non-Profit non-Governmental Organization with mission of assuring Quality of Medicines. Main responsibilities are to engage with USP Stakeholders, mainly National Regulatory Authorities, National Control Laboratories, International Organization like WHO, Pharmaceutical Association, Drug Policy Makers with topics and initiatives related to Heath and Quality.

Dr Kurdi has over 30 years of experience in pharmaceutical industry in Quality Control, Quality Assurance, Research and Development, Regulatory Affairs, Commercial and Business Development including Technology Transfer (TT) as well licensing activities. Dr Kurdi held executive and management position during her work with Pharmaceutical Industry.

Additionally, Dr Kurdi served as a member with more than committee nationally and international; with JFDA on re-registration of generic products, Control of Pharmaceutical Products, Control of Active Pharmaceutical Ingredient used in Pharmaceutical Product, Value Added Medicine and Site Accreditation Committee.

With United State Pharmacopeia as an expert in the advisory panels of General Chapter (1197) and with International Generic and Biosimilar Medicine Association (IGBA) representing JAPM in Biosimilar Committee.

Dr Kurdi has many research papers published in Scientific Journals and she is frequent speaker in Pharmaceutical Conferences.